192 related articles for article (PubMed ID: 15324960)
1. [Indications and limits of recombinant human erythropoietin in intensive care unit].
Ventré C; Rousseau S; Albanèse J; Leone M; Martin C
Ann Fr Anesth Reanim; 2004 Jul; 23(7):714-21. PubMed ID: 15324960
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
3. Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR
Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
[TBL] [Abstract][Full Text] [Related]
4. Use of exogenous erythropoietin in critically ill patients.
MacLaren R; Gasper J; Jung R; Vandivier RW
J Clin Pharm Ther; 2004 Jun; 29(3):195-208. PubMed ID: 15153081
[TBL] [Abstract][Full Text] [Related]
5. The role of erythropoietin therapy in the critically ill.
Corwin HL
Transfus Med Rev; 2006 Jan; 20(1):27-33. PubMed ID: 16373185
[TBL] [Abstract][Full Text] [Related]
6. Anemia and red blood cell transfusion in the critically ill.
Corwin HL
Semin Dial; 2006; 19(6):513-6. PubMed ID: 17150052
[TBL] [Abstract][Full Text] [Related]
7. Is a prophylactic treatment by erythropoietin relevant to reduce red blood cell transfusion in the pediatric intensive care unit?
Liet JM; Paranon S; Baraton L; Dejode JM; Rozé JC
Pediatr Crit Care Med; 2006 Nov; 7(6):541-4. PubMed ID: 17006380
[TBL] [Abstract][Full Text] [Related]
8. Anemia in critical illness.
Eckardt KU
Wien Klin Wochenschr; 2001 Feb; 113(3-4):84-9. PubMed ID: 11253745
[TBL] [Abstract][Full Text] [Related]
9. Removal of erythropoietin from anaemia trauma practice guideline does not increase red blood cell transfusions and decreases hospital utilization costs.
Christmas AB; Camp SM; Barrett MC; Schmelzer TM; Norton HJ; Huynh TT; Thomason MH; Sing RF
Injury; 2009 Dec; 40(12):1330-5. PubMed ID: 19595325
[TBL] [Abstract][Full Text] [Related]
10. Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients.
Beguin Y
Haematologica; 2002 Nov; 87(11):1209-21. PubMed ID: 12414352
[TBL] [Abstract][Full Text] [Related]
11. Understanding and managing anemia in critically ill patients.
Pearl RG; Pohlman A
Crit Care Nurse; 2002 Dec; Suppl():1-12; discussion 12-4; quiz 15-6. PubMed ID: 12518573
[TBL] [Abstract][Full Text] [Related]
12. Packed red blood cell transfusion in the intensive care unit: limitations and consequences.
Gould S; Cimino MJ; Gerber DR
Am J Crit Care; 2007 Jan; 16(1):39-48; quiz 49. PubMed ID: 17192525
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin in clinical practice: current use, effect on survival, and future directions.
Oster HS; Hoffman M; Prutchi-Sagiv S; Katz O; Neumann D; Mittelman M
Isr Med Assoc J; 2006 Oct; 8(10):703-6. PubMed ID: 17125118
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based red cell transfusion in the critically ill: quality improvement using computerized physician order entry.
Rana R; Afessa B; Keegan MT; Whalen FX; Nuttall GA; Evenson LK; Peters SG; Winters JL; Hubmayr RD; Moore SB; Gajic O;
Crit Care Med; 2006 Jul; 34(7):1892-7. PubMed ID: 16691136
[TBL] [Abstract][Full Text] [Related]
15. Time course of anemia during six months follow up following intensive care discharge and factors associated with impaired recovery of erythropoiesis.
Bateman AP; McArdle F; Walsh TS
Crit Care Med; 2009 Jun; 37(6):1906-12. PubMed ID: 19384207
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response.
Vanstraelen G; Baron F; Willems E; Bonnet C; Hafraoui K; Frère P; Fillet G; Beguin Y
Exp Hematol; 2006 Jul; 34(7):841-50. PubMed ID: 16797411
[TBL] [Abstract][Full Text] [Related]
17. Transfusion practice in the critically ill.
Corwin HL; Surgenor SD; Gettinger A
Crit Care Med; 2003 Dec; 31(12 Suppl):S668-71. PubMed ID: 14724464
[TBL] [Abstract][Full Text] [Related]
18. Recombinant human erythropoietin in cancer-related anemia: an evidence-based review.
Desai J; Demetri GD
Best Pract Res Clin Haematol; 2005; 18(3):389-406. PubMed ID: 15792913
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of preoperative erythropoietin administration in pediatric neuromuscular scoliosis patients.
Vitale MG; Privitera DM; Matsumoto H; Gomez JA; Waters LM; Hyman JE; Roye DP
Spine (Phila Pa 1976); 2007 Nov; 32(24):2662-7. PubMed ID: 18007241
[TBL] [Abstract][Full Text] [Related]
20. Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study.
Chant C; Wilson G; Friedrich JO
Crit Care; 2006; 10(5):R140. PubMed ID: 17002795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
